- Report
- March 2022
- 88 Pages
Global
€3327EUR$3,600USD£2,799GBP
- Report
- January 2022
- 37 Pages
United States
- Report
- January 2022
- 14 Pages
Europe
- Report
- February 2024
- 75 Pages
Global
From €4574EUR$4,950USD£3,849GBP
- Report
- November 2023
- 78 Pages
Global
From €2264EUR$2,450USD£1,905GBP
- Report
- October 2022
- 71 Pages
Global
- Report
- November 2021
- 106 Pages
Global
From €4574EUR$4,950USD£3,849GBP
- Report
- May 2024
- 90 Pages
Global
From €5498EUR$5,950USD£4,626GBP
- Report
- December 2021
- 120 Pages
Global
From €2310EUR$2,500USD£1,944GBP
- Report
- August 2022
- 128 Pages
Global
From €4112EUR$4,450USD£3,460GBP
- Report
- January 2025
- 55 Pages
India
- Report
- April 2022
- 51 Pages
India
- Report
- March 2021
- 64 Pages
India
- Report
- October 2019
India
- Report
- June 2019
- 71 Pages
Global
€2726EUR$2,950USD£2,294GBP
- Report
- March 2023
- 49 Pages
Global
From €2310EUR$2,500USD£1,944GBP
- Report
- April 2024
- 136 Pages
Global
From €2771EUR$2,999USD£2,332GBP
- Report
- April 2024
- 135 Pages
Global
From €2771EUR$2,999USD£2,332GBP
- Report
- April 2024
- 136 Pages
Global
From €2771EUR$2,999USD£2,332GBP
- Report
- February 2025
- 80 Pages
South Korea
From €3650EUR$3,950USD£3,071GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more